Acid reflux
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Acquired aplastic anemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Herein, gene expression analysis identified a significant loss of the SWI/SNF core component SMARCC1, along with ARID1B, ACTL6A, and SMARCD1, in human AA BM CD34<sup>+</sup> HSCs and hematopoietic stem and progenitor cells (HSPCs) compared with normal HSPCs.
|
29596882 |
2018 |
Acute Promyelocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
To identify the genes that may participate in the development of APL, we analyzed data from an APL cDNA microarray (GSE12662) in the NCBI database, and found that ACTL6A was up-regulated in APL patients.
|
30448346 |
2019 |
Adult Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.
|
23728344 |
2014 |
Aplasia/Hypoplasia of the nails
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Atrial Septal Defects
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
|
|
|
Broad nasal tip
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Broad thumbs
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Increased Actin-like 6A (ACTL6A) expression has been implicated in the development of diverse cancers and recently associated with the Hippo signaling pathway, which is known to regulate biological properties, including proliferation, tissue regeneration, stem cell biology, as well as tumorigenesis.
|
29725063 |
2018 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Ectopic ACTL6A/p63 expression promotes tumorigenesis, while ACTL6A expression and YAP activation are highly correlated in primary HNSCC and predict poor patient survival.
|
28041841 |
2017 |
Carcinoma, Ovarian Epithelial
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, the roles of ACTL6A in the development of ovarian cancer and the regulation of cancer glucose metabolism are mostly unknown.
|
31649264 |
2019 |
Cervix carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We found that BAF53 knockdown led to suppression of expression of E6 and E7 genes from HPV integrants in cervical carcinoma cell lines HeLa and SiHa.
|
21821000 |
2011 |
Childhood Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, data from the present study demonstrated that ACTL6A was associated with poor survival and promoted osteosarcoma cell metastasis through EMT, suggesting that ACTL6A may be a novel prognostic biomarker and therapeutic target for osteosarcoma.
|
28260090 |
2017 |
Childhood Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.
|
23728344 |
2014 |
Cleft anterior mitral valve leaflet
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Coarse facial features
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Colon adenoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The data from both the Gene Expression Omnibus (GEO) and Oncomine databases showed that ACTL6A expression levels in colon adenoma and cancer were higher than those in normal colon samples.
|
30348114 |
2018 |
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The ACTL6A expression level in fresh colon cancer specimens was also higher than that in the corresponding adjacent normal colon specimens.
|
30348114 |
2018 |
Delayed speech and language development
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Developmental delay (disorder)
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.
|
28649782 |
2017 |
Glioma
|
0.020 |
Biomarker
|
disease |
BEFREE |
ACTL6A promotes malignant behaviors of glioma cells in vitro and in orthotopic xenograft model.
|
29725063 |
2018 |
Glioma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Therefore, BAF53a could be a potential promising biomarker and a target for the treatment of glioma.
|
29039584 |
2017 |
Global developmental delay
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.
|
28649782 |
2017 |
Hernia, Inguinal
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Intellectual Disability
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Thus, ACTL6A gene mutation analysis should be considered in patients with intellectual disability, learning disabilities, or developmental language disorder.
|
28649782 |
2017 |